一盒依普利酮卖多少钱呢？

(Eplerenone) is a new type of selective aldosterone receptor blocker, used for essential hypertension and heart failure after myocardial infarction. For severe hypertension that cannot be controlled by a combination of multiple antihypertensive drugs, the addition of eplerenone can significantly reduce blood pressure, especially the decrease in systolic blood pressure is more significant. Combined treatment with angiotensin-converting enzyme inhibitors (ACEI) and beta-blockers can improve patients' quality of life and reduce mortality in severe heart failure and myocardial infarction.

It was approved for clinical use by the U.S. Food and Drug Administration in 2002. It has a stronger antagonizing effect on aldosterone than spironolactone, and has extremely low affinity for androgen and progesterone receptors. It has few adverse reactions. It has definite efficacy in the treatment of hypertension, heart failure and myocardial infarction, has fewer adverse reactions and is well tolerated.

Eplerenone currently on the market includes the original drug of Pfizer’s eplerenone in the United States and the generic version of eplerenone from India’s Lupine Pharmaceuticals. Different versions of eplerenone have different prices. Let’s take a look:

Eplerenone marketed in the United States is produced by Pfizer Ltd./Pfizer Pharmaceuticals of the United States. It has two specifications, with different prices according to different rules: Pharmaceutical specification 1: 25mg-30 tablet bottle/box, price: $118.71/USD; Pharmaceutical specification 2: 50mg-30 tablet bottle/box, price: $124.09/USD.

Eplerenone marketed in India is produced by Lupine Pharmaceuticals of India. Pharmaceutical specification 1: 25mg-15 tablets/box, price: MRP286.5/unit: Indian rupees; pharmaceutical specification 2: 50mg-10 tablets/box/box, price: MRP356.6/unit: Indian rupees. Specification 3: 50mg-100 tablets/box is equivalent to about RMB 500$.